Patrick-Pascal Strunz1, Maxime Le Maire2, Tobias Heusinger2, Ludwig Hammel3, Michael Gernert4, Eva C Schwaneck4,5, Johanna Callhoff6,7, Jan Portegys4, Marc Schmalzing4, Hans-Peter Tony4, Matthias Froehlich4. 1. Medizinische Klinik II, Abteilung für Rheumatologie und klinische Immunologie, Universitätsklinikum Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Deutschland. Strunz_p@ukw.de. 2. Medizinische Fakultät, Universität Würzburg, Würzburg, Deutschland. 3. Deutsche Vereinigung Morbus Bechterew e. V., Schweinfurt, Deutschland. 4. Medizinische Klinik II, Abteilung für Rheumatologie und klinische Immunologie, Universitätsklinikum Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Deutschland. 5. Asklepios Klinik Altona, Hamburg, Deutschland. 6. Epidemiologie, Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Berlin, Deutschland. 7. Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
Abstract
BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among axSpA patients was conducted to determine the need for an axSpA exercise app. MATERIALS AND METHODS: An anonymous online survey among axSpA patients of the German Bechterew's Disease Association was conducted using a questionnaire; data were analysed using Excel, and GraphPad Prism. RESULTS: Four hundred and thirty-five axSpA patients participated in the survey. Eighty-four percent of the participants responded that there is a need to develop an axSpA-specific exercise app, and the same proportion want to use it. Patients under 60 years, patients under 60 years on biologics or Janus kinase inhibitor therapy, and patients with frequent back pain reported a greater need than their respective control subgroups (p < 0.001 in each case). CONCLUSION: The development of an exercise app for axSpA is considered necessary by a large proportion of the patients; younger and more intensively treated patients appear to have a greater need.
BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among axSpA patients was conducted to determine the need for an axSpA exercise app. MATERIALS AND METHODS: An anonymous online survey among axSpA patients of the German Bechterew's Disease Association was conducted using a questionnaire; data were analysed using Excel, and GraphPad Prism. RESULTS: Four hundred and thirty-five axSpA patients participated in the survey. Eighty-four percent of the participants responded that there is a need to develop an axSpA-specific exercise app, and the same proportion want to use it. Patients under 60 years, patients under 60 years on biologics or Janus kinase inhibitor therapy, and patients with frequent back pain reported a greater need than their respective control subgroups (p < 0.001 in each case). CONCLUSION: The development of an exercise app for axSpA is considered necessary by a large proportion of the patients; younger and more intensively treated patients appear to have a greater need.
Authors: H Haibel; I Redeker; A Zink; J Callhoff; U Marschall; F Hoffmann; J Sieper; D Poddubnyy Journal: Z Rheumatol Date: 2019-11 Impact factor: 1.372
Authors: U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking Journal: Z Rheumatol Date: 2019-12 Impact factor: 1.372
Authors: Janet R Millner; John S Barron; Kirsty M Beinke; Rachael H Butterworth; Briony E Chasle; Lindsay J Dutton; Margaret A Lewington; Errol G S Lim; Tony B Morley; Jennie E O'Reilly; Kathryn A Pickering; Tania Winzenberg; Jane Zochling Journal: Semin Arthritis Rheum Date: 2015-08-18 Impact factor: 5.532